Browsing Tag
Manish Dhanuka
2 posts
Orchid Pharma company profile: business model, financials, and growth outlook (2026 Edition)
Orchid Pharma Limited company profile: cephalosporin API leader, FY2025 revenue Rs. 921.93 Cr, Jammu PLI expansion, novel antibiotic pipeline, and 2026-27 growth outlook.
April 4, 2026
Orchid Pharma bags FDA approval for Enmetazobactam, first Indian-invented beta lactamase inhibitor
Chennai-based Orchid Pharma has achieved a significant milestone by receiving approval from the United States Food and Drug…
February 24, 2024